Asset Manager

Updated:

Shavit Capital

Shavit Capital is an investment practice that specializes in late-stage investments in Israeli and Israeli-related companies. Founded in 2008, it has over $500...

Shavit Capital logo

Shavit Capital

Shavit Capital is an investment practice that specializes in late-stage investments in Israeli and Israeli-related companies. Founded in 2008, it has over $500 million under management across five separate private equity funds. The Funds invest in equity mezzanine or bridge rounds in companies which subsequently expect to raise larger amounts pursuant to an IPO or dual listing, and also invest in other late-stage opportunities including PIPEs.

General information

Firm type

Generalist

Year founded

2008

Location

Region

Middle East

Country

Israel

City

Jerusalem

Corporate office

Jerusalem Technology Park – Malcha, Derech Agudat Sport HaPo'el 1, Erez Building, Entrance B, 4th Floor, Jerusalem, Israel 9695101

Principals

Gary Leibler

Founder and Managing Partner

Leon Recanati

Partner and Chairman of Investment Committee

Gabriel Menaged

Partner

Jonathan Leibler

Partner

Daniel Meron

Partner

David Frohmann

Chief Financial Officer

Sector focus

Enterprise SoftwareDigital HealthFinTechIndustrial TechHealthcare Services

Frequently asked questions

Who makes investment decisions at Shavit Capital?

Gary Leibler, as founder and managing partner, leads the firm. The investment committee is chaired by partner Leon Recanati, and the broader partnership includes Gabriel Menaged, Jonathan Leibler, and Daniel Meron. This group collectively oversees deal evaluation and approval.

How does Shavit Capital source its deal flow?

Shavit sources opportunities from within the Israeli technology ecosystem, leveraging its partners' networks and the country's dense pipeline of growth-stage private companies. Its venture partners — Asaf Iram, Neil Cohen, and Erez Yuval — extend the firm's origination reach into cross-border and sector-specific opportunities.

Which sectors has Shavit Capital backed?

Its portfolio historically spans medical devices (Alpha TAU), fintech (eToro Group), biopharma (Chemomab Therapeutics, Foamix Pharmaceuticals), and enterprise technology. The firm focuses on sectors where Israeli companies have demonstrated exportable innovation.

What is the relationship between Shavit Capital and Recanati family interests?

Leon Recanati serves as partner and chairman of Shavit Capital's investment committee, bringing institutional governance to the partnership. The Recanati family is well-known in Israeli business circles, but Shavit operates as an independent fund manager rather than a dedicated family investment vehicle.

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on asset managers?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo

More Jerusalem Generalist profiles